Blog dermatologico
Elenco degli articoli con argomento «psoriasi»
2019
Tofacitinib in Pediatric Psoriasis: An Open-Label Trial to Study Its Safety and Efficacy in Children
RicercaPsoriasis is a chronic, multifactorial, inflammatory disorder, with an estimated prevalence of 0.71% in children....
Leggi tutto2019
Skin changes in the obese patient
RicercaObesity is a worldwide major public health problem with an alarmingly increasing prevalence over the past 2 decades....
Leggi tutto2019
Risk of Major Cardiovascular Events in Patients with Psoriasis Receiving Biologic Therapies: a Prospective Cohort Study.
RicercaThe cardiovascular safety profile of biologic therapies used for psoriasis is unclear....
Leggi tutto
2019
Psoriasi: farmaci biologici sempre più efficaci e sicuri
Rassegna stampaGli anticorpi migliorano significativamente i sintomi della malattia. No al “fai da te”. Sul web troppi video privi di contenuto scientifico...
Leggi tutto
2019
La psoriasi è la malattia dei sani
E' vero che ...E' vero che ... La psoriasi è la malattia dei sani...
Leggi tutto2019
Dietary compounds as potential modulators of microRNA expression in psoriasis
RicercaThis review aims to summarize knowledge about aberrant microRNAs expression in psoriasis...
Leggi tutto2019
Psoriasi a placche, Fda approva farmaco per l'uso negli adolescenti dai 12 anni di età
Rassegna stampaLa Food and Drug Administration (FDA) degli Stati Uniti ha approvato calcipotriene 0,005% formulato in schiuma, commercializzato da Mayne Pharma Group, per il trattamento della psoriasi a placche del cuoio capelluto e del corpo negli a...
Leggi tutto2019
Effects of psoriasis treatment on genital warts: a case report.
RicercaThe use of immunosuppressive drugs predisposes to infections, as they block the most important stage in antiviral defense, which is the cytotoxic T-lymphocyte HLA-dependent response....
Leggi tutto2019
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission.
RicercaThere is increasing interest in discontinuing biological therapies in patients with chronic plaque psoriasis (PsO) who achieve a complete clinical remission, provided patients maintain clinical benefit....
Leggi tutto2019
Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis
Ricerca2019 May 24;9:29-35. doi: 10.2147/PTT.S179283. eCollection 2019....
Leggi tutto
2019
2019
Task Force "Psoriasi nella donna in età fertile” al WCD
NewsInterventi del gruppo Psoriasi al Word Congress of Dermatology...
Leggi tutto2019
Moderate-to-severe psoriasis and pregnancy: impact on fertility, pregnancy outcome and treatment perspectives.
RicercaPsoriasis affects 2-4% of the world’s population...
Leggi tutto2019
Safety and efficacy of Certolizumab Pegol in a real-life cohort of patients with Psoriasis and Psoriatic Arthritis
RicercaAim of this observational study was to assess safety and efficacy of Certolizumab Pegol(CZP) in a real-life cohort of patients affected by psoriasis(PsO) and psoriatic arthritis(PsA), who had an inadequate response to previous systemic...
Leggi tutto2019
Ultrasound assessment of the keratolitic effect of a 50% urea anhydrous paste on psoriasis plaques: a prospective study
RicercaThe keratolytic effect of urea is well-known, although the majority of the available studies rely on clinical observation only. The aim of this open trial was to evaluate, through clinical and ultrasound assessment, the efficacy and to...
Leggi tutto2019
Efficacy of secukinumab without the initial weekly loading dose in patients with chronic plaque psoriasis
RicercaSecukinumab is administered at the labelled dose of 300 mg at weeks 0, 1, 2, 3, 4 (loading dose) and every 4 weeks thereafter...
Leggi tutto2019
Secukinumab shows high efficacy irrespective of HLA‐Cw6 status in patients with moderate to severe plaque‐type psoriasis
RicercaRecent studies have shown that biological drugs approved for treating psoriasis and psoriatic arthritis are not effective in all patients, and that variations in the genome have been associated with different clinical responses or side...
Leggi tutto2019
Oltre 2 milioni gli italiani con psoriasi
Rassegna stampaLa psoriasi colpisce il 3% della popolazione mondiale e nel 10-20% dei casi si presenta in forma grave o medio-grave. In Italia soffre di questa patologia autoimmune il 3-4% della popolazione pari a circa 2,5 milioni di persone....
Leggi tutto
2019
Psoriasi: grazie alle nuove terapie miglioramenti fino al 90% in poche settimane
Rassegna stampaCon l’arrivo dei nuovi farmaci, oggi il trattamento di questa malattia infiammatoria è in grado di restituire ai pazienti una pelle pulita senza effetti collaterali pesanti. Ma è importante fare riferimento al dermatologo per una d...
Leggi tutto2019
Dermoscopic features of psoriasis of the skin, scalp and nails – a systematic review
RicercaDermoscopy is a non‐invasive in‐office method, which enables the diagnosis of many dermatoses and reduces the need for performing biopsies....
Leggi tutto